Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Meng-Jer Hsieh, Ning-Hung Chen, Shih-Lung Cheng, Chi-Wei Tao, Yu-Feng Wei, Yao-Kuang Wu, Ming-Cheng Chan, Shih-Feng Liu, Wu-Huei Hsu, Tsung-Ming Yang, Ming-Shian Lin, Ching-Lung Liu, Ping-Hung Kuo & Ying-Huang Tsai. (2022) Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 967-976.
Read now
Read now
Nuzhat Afroz, Florian S Gutzwiller, Alex J Mackay, Christel Naujoks, Francesco Patalano & Konstantinos Kostikas. (2020) Patient-Reported Outcomes (PROs) in COPD Clinical Trials: Trends and Gaps. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1789-1800.
Read now
Read now
Pablo Altman, Miguel A. Bergna, Gabriel R. Garcia, Tadhg Guerin, Andrea V. Pino & John L. Whiteford. (2019) Patient perception of Breezhaler® and Ellipta® device feedback mechanisms in COPD: The ADVANTAGE Study. Current Medical Research and Opinion 35:2, pages 221-227.
Read now
Read now
Antonello Nicolini, Bruna Grecchi, Maura Ferrari-Bravo & Cornelius Barlascini. (2018) Safety and effectiveness of the high-frequency chest wall oscillation vs intrapulmonary percussive ventilation in patients with severe COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 617-625.
Read now
Read now
Nikolas Bernhard, Philipp M Lepper, Claus Vogelmeier, Martina Seibert, Stefan Wagenpfeil, Robert Bals & Sebastian Fähndrich. (2017) Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency – analysis from the German Registry. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1427-1437.
Read now
Read now
H. Gunen, O. Kilinc, M. Polatli, M. Suerdem & E. Uzaslan. (2016) Modification of the GOLD recommendations for chronic obstructive pulmonary disease to broaden their usage in Turkey. Expert Review of Respiratory Medicine 10:6, pages 625-628.
Read now
Read now
Yoshinosuke Fukuchi, Koichiro Tatsumi, Hiromasa Inoue, Yukinori Sakata, Kai Shibata, Hideaki Miyagishi, Yasuhiro Marukawa & Masakazu Ichinose. (2016) Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 831-838.
Read now
Read now
Magnus Ekström, Josefin Sundh & Kjell Larsson. (2016) Patient reported outcome measures in chronic obstructive pulmonary disease: Which to use?. Expert Review of Respiratory Medicine 10:3, pages 351-362.
Read now
Read now
Articles from other publishers (29)
Omar Ammous, Walid Feki, Tamara Lotfi, Assem M Khamis, Rik Gosselink, Ahmed Rebai & Samy Kammoun. (2023) Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews 2023:1.
Crossref
Crossref
Anja Frei, Thomas Radtke, Kaba Dalla Lana, Patrick Brun, Thomas Sigrist, Marc Spielmanns, Swantje Beyer, Thomas F. Riegler, Gilbert Büsching, Sabine Spielmanns, Ramona Kunz, Tamara Cerini, Julia Braun, Yuki Tomonaga, Miquel Serra-Burriel, Ashley Polhemus & Milo A. Puhan. (2022) Effectiveness of a Long-term Home-Based Exercise Training Program in Patients With COPD After Pulmonary Rehabilitation. Chest 162:6, pages 1277-1286.
Crossref
Crossref
Maria T. PESTELLI, Francesco D’ABROSCA, Paola TOGNETTI, Bruna GRECCHI, Antonello NICOLINI & Paolo SOLIDORO. (2022) Do not forget the lungs: preliminary feasibility study on I/E mode physiotherapy for people recovering from COVID-19. Panminerva Medica 64:2.
Crossref
Crossref
Antonello NICOLINI, Bruna GRECCHI & Paolo BANFI. (2022) Effectiveness of two high-frequency chest wall oscillation techniques in patients with bronchiectasis: a randomized controlled preliminary study. Panminerva Medica 64:2.
Crossref
Crossref
Arie C. Verburg, Simone A. van Dulmen, Henri Kiers, Maria W.G. Nijhuis-van der Sanden & Philip J. van der Wees. (2022) A practice test and selection of a core set of outcome-based quality indicators in Dutch primary care physical therapy for patients with COPD: a cohort study. ERJ Open Research 8:3, pages 00008-2022.
Crossref
Crossref
Sara Souto-Miranda, Guilherme Rodrigues, Martijn A. Spruit & Alda Marques. (2022) Pulmonary rehabilitation outcomes in individuals with chronic obstructive pulmonary disease: A systematic review. Annals of Physical and Rehabilitation Medicine 65:3, pages 101564.
Crossref
Crossref
Dave Singh, Jutta Beier, Carol Astbury, Maria G. Belvisi, Carla A. Da Silva, Alexandra Jauhiainen, Eulalia Jimenez, Alejhandra Lei, Sofia Necander, Jaclyn A. Smith, Ulrika Wählby Hamrén, Wenjing Xin & Ioannis Psallidas. (2022) The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD. European Respiratory Journal 59:4, pages 2100972.
Crossref
Crossref
Alexandra Strassmann, Mathias Guler, Claudia Steurer-Stey, Kaba Dalla Lana, Tania Carron, Julia Braun, Philippe Giroud, Isabelle Peytremann-Bridevaux, Milo A. Puhan & Anja Frei. (2022) Nationwide implementation of the self-management program “Living well with COPD”: Process and effectiveness evaluation using a mixed-methods approach. Patient Education and Counseling 105:3, pages 670-678.
Crossref
Crossref
Bo-Guen Kim, Sun Hye Shin, Hyun-Il Gil, Sungmin Zo, Yunjoo Im, Ju Yeun Song, Chai Young Lee, Danbee Kang, Juhee Cho & Hye Yun Park. (2022) Change in individual chronic obstructive pulmonary disease assessment test item scores after short-term bronchodilator therapy and its impact on exacerbation in treatment-naïve patients with chronic obstructive pulmonary disease. Therapeutic Advances in Chronic Disease 13, pages 204062232211142.
Crossref
Crossref
Neo M. Tapela, Luz Fialho, Martin Ingvar & Suzanne Gaunt. (2021) What It Will Take to Achieve High-Value Patient-Centered Care Globally. Journal of Healthcare Management Standards 1:2, pages 111-121.
Crossref
Crossref
Dave Singh, James F. Donohue, Isabelle H. Boucot, Neil C. Barnes, Chris Compton & Fernando J. Martinez. (2021)
Future concepts in bronchodilation for COPD: dual-
versus
monotherapy
. European Respiratory Review 30:160, pages 210023.
Crossref
Crossref
Carey Meredith Suehs, Maéva Zysman, Cécile Chenivesse, Pierre-Régis Burgel, F Couturaud, Gaëtan Deslee, Patrick Berger, Chantal Raherison, Gilles Devouassoux, Christophe Brousse, Nicolas Roche, Mathieu Molimard, Thierry Chinet, Philippe Devillier, Pascal Chanez, Romain Kessler, Alain Didier, Yan Martinat, Olivier Le Rouzic & A Bourdin. (2020) Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus study. BMJ Open 10:7, pages e035811.
Crossref
Crossref
Harma Alma, Corina de Jong, Janwillem Kocks & Thys van der Molen. (2020) Commentary: “Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease” by Dankers M et al. in Frontiers in Pharmacology 2020; 10: 1519. Frontiers in Pharmacology 11.
Crossref
Crossref
Howard S. Kim, D. Mark Courtney, Danielle M. McCarthy & David Cella. (2020) Patient‐reported Outcome Measures in Emergency Care Research: A Primer for Researchers, Peer Reviewers, and Readers. Academic Emergency Medicine 27:5, pages 403-418.
Crossref
Crossref
Claus F. Vogelmeier, Miguel Román-Rodríguez, Dave Singh, MeiLan K. Han, Roberto Rodríguez-Roisin & Gary T. Ferguson. (2020) Goals of COPD treatment: Focus on symptoms and exacerbations. Respiratory Medicine 166, pages 105938.
Crossref
Crossref
Anja Frei, Thomas Radtke, Kaba Dalla Lana, Julia Braun, Ramona M. Müller & Milo A. Puhan. (2019) Effects of a long-term home-based exercise training programme using minimal equipment vs. usual care in COPD patients: a study protocol for two multicentre randomised controlled trials (HOMEX-1 and HOMEX-2 trials). BMC Pulmonary Medicine 19:1.
Crossref
Crossref
Riju Ray, Beth Hahn, Richard H. Stanford, John White, Breanna Essoi & Alyssa Goolsby Hunter. (2019) Classification of Patients with COPD on LAMA Monotherapy Using the GOLD Criteria: Analysis of a Claims-Linked Patient Survey Study. Pulmonary Therapy 5:2, pages 191-200.
Crossref
Crossref
Beth Hahn, Richard H. Stanford, Alyssa Goolsby Hunter, John White, Breanna Essoi & Riju Ray. (2019) Predictors of Symptom Burden in Patients with COPD on LAMA Monotherapy: Multivariable Analysis of a Claims-Linked Survey Study. Pulmonary Therapy 5:2, pages 179-190.
Crossref
Crossref
Aernout Haarst, Lorcan McGarvey & Sabina Paglialunga. (2019)
Review of Drug Development Guidance to Treat Chronic Obstructive Pulmonary Disease:
US
and
EU
Perspectives
. Clinical Pharmacology & Therapeutics 106:6, pages 1222-1235.
Crossref
Crossref
Li Feng, Jean Delacoste, David Smith, Joseph Weissbrot, Eric Flagg, William H Moore, Francis Girvin, Roy Raad, Priya Bhattacharji, David Stoffel, Davide Piccini, Matthias Stuber, Daniel K Sodickson, Ricardo Otazo & Hersh Chandarana. (2019) Simultaneous Evaluation of Lung Anatomy and Ventilation Using 4D Respiratory-Motion-Resolved Ultrashort Echo Time Sparse MRI. Journal of Magnetic Resonance Imaging 49:2, pages 411-422.
Crossref
Crossref
Harma Alma, Corina de Jong, Ioanna Tsiligianni, Robbert Sanderman, Janwillem Kocks & Thys van der Molen. (2018) Clinically relevant differences in COPD health status: systematic review and triangulation. European Respiratory Journal 52:3, pages 1800412.
Crossref
Crossref
Hélder Melro, Jorge Gomes, Gabriela Moura & Alda Marques. (2018) Genetic profile and patient-reported outcomes in chronic obstructive pulmonary disease: A systematic review. PLOS ONE 13:6, pages e0198920.
Crossref
Crossref
Antonello Nicolini, Valentina Mascardi, Bruna Grecchi, Maura Ferrari-Bravo, Paolo Banfi & Cornelius Barlascini. (2018) Comparison of effectiveness of temporary positive expiratory pressure versus oscillatory positive expiratory pressure in severe COPD patients. The Clinical Respiratory Journal 12:3, pages 1274-1282.
Crossref
Crossref
Raolat M. Abdulai, Tina Jellesmark Jensen, Naimish R. Patel, Michael I. Polkey, Paul Jansson, Bartolomé R. Celli & Stephen I. Rennard. (2018) Deterioration of Limb Muscle Function during Acute Exacerbation of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 197:4, pages 433-449.
Crossref
Crossref
Nobuyuki Horita. 2018. Clinical Relevance of Genetic Factors in Pulmonary Diseases. Clinical Relevance of Genetic Factors in Pulmonary Diseases
57
75
.
Anja Frei & Milo Puhan. 2018. Textbook of Pulmonary Rehabilitation. Textbook of Pulmonary Rehabilitation
93
107
.
Annerika Slok, Daniel Kotz, Niels Chavannes, Jiska Snoeck-Stroband, Philippe Salomé & Johannes in ’t Veen. (2017) De Ziektelastmeter COPD als hulpmiddel in de praktijk. Huisarts en wetenschap 60:10, pages 500-502.
Crossref
Crossref
S. N. Avdeev, N. A. Guseva & G. S. Nuralieva. (2016) Efficacy of high frequency chest wall oscillation method in acute exacerbation of chronic obstructive pulmonary disease. PULMONOLOGIYA 26:4, pages 466-472.
Crossref
Crossref
S. N. Avdeev, Z. R. Aysanov, A. S. Belevskiy, A. A. Vizel'G. L. Ignatova, N. P. Knyazheskaya, I. V. Leshchenko, S. I. Ovcharenko, V. I. TrofimovE. I. Shmelev. (2016) Perspectives of pharmacological therapy of chronic obstructive pulmonary disease: opportunities of dual bronchodilation and a role of inhaled steroids. Expert Council Consensus. PULMONOLOGIYA 26:1, pages 65-72.
Crossref
Crossref